Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leach

Showing results (311-320 of 326) with videos related to

Pageof 33
Sort By:
Chemistry & Biology|November 29, 2011
Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymesMikael Altun, Holger B Kramer, Lianne I Willems, et al.
Oncotarget|November 19, 2015
Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Journal of Manipulative and Physiological Therapeutics|October 17, 2012
Chiropractic care and public health: answering difficult questions about safety, care through the lifespan, and community actionClaire Johnson, Sidney M Rubinstein, Pierre Côté, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Oncotarget|May 13, 2015
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Nature Communications|February 24, 2021
Genome assembly and population genomic analysis provide insights into the evolution of modern sweet cornYing Hu, Vincent Colantonio, Bárbara S F Müller, et al.
Pageof 33

Showing results (311-320 of 326) with videos related to

Sort By:
Pageof 33
Chemistry & Biology|November 29, 2011
Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymesMikael Altun, Holger B Kramer, Lianne I Willems, et al.
Oncotarget|November 19, 2015
Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Journal of Manipulative and Physiological Therapeutics|October 17, 2012
Chiropractic care and public health: answering difficult questions about safety, care through the lifespan, and community actionClaire Johnson, Sidney M Rubinstein, Pierre Côté, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Oncotarget|May 13, 2015
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2003
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2Josie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Nature Communications|February 24, 2021
Genome assembly and population genomic analysis provide insights into the evolution of modern sweet cornYing Hu, Vincent Colantonio, Bárbara S F Müller, et al.
Pageof 33